This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Valeant Pharmaceuticals International Inc (VRX)

NYSE: Health Care

Company Balance Sheet
Dec 2014 Dec 2013 Dec 2012 Dec 2011
Assets
Cash and Equivalents 322.60M 600.34M 916.09M 164.11M
Receivables 2.08B 1.81B 913.84M 577.50M
Inventories 950.60M 882.97M 531.26M 355.21M
Other Current Assets 8.90M 15.94M 90.98M 72.24M
Total Current Assets 4.19B 3.89B 2.78B 1.36B
Property, Plant & Equipment, Gross 2.29B 2.07B 636.23M 540.03M
Accumulated Depreciation & Depletion 977.90M 838.84M 173.51M 125.79M
Property, Plant & Equipment, Net 1.31B 1.23B 462.72M 414.24M
Intangibles 11.26B 12.85B 9.31B 7.66B
Other Non-Current Assets 193.10M 195.47M 183.75M 58.70M
Total Non-Current Assets 22.16B 24.08B 15.17B 11.78B
Liabilities & Shareholder Equity
Total Assets 26.35B 27.97B 17.95B 13.14B
Accounts Payable 398.00M 326.97M 227.38M 157.62M
Short Term Debt 7.10M 204.76M 480.18M 111.25M
Other Current Liabilities 559.00M 114.46M 19.91M 110.60M
Total Current Liabilities 2.73B 2.51B 1.82B 924.27M
Long Term Debt 15.25B 17.16B 10.54B 6.54B
Deferred Income Taxes 2.33B 2.32B 1.35B 1.24B
Other Non-Current Liabilities 603.90M 742.93M 522.82M 434.65M
Minority Interest -1.30M 2.47M 0.00 0.00
Total Non-Current Liabilities 18.31B 20.34B 12.41B 8.21B
Total Liabilities 21.04B 22.85B 14.23B 9.13B
Preferred Stock Equity 0.00 0.00 0.00 0.00
Common Stock Equity 5.31B 5.12B 3.72B 4.01B
Common Par 0.00 0.00 0.00 0.00
Additional Paid In Capital 8.59B 8.53B 6.21B 6.24B
Cumulative Translation Adjustment 0.00 0.00 0.00 0.00
Retained Earnings -2.36B -3.28B -2.37B -2.03B
Treasury Stock 0.00 0.00 0.00 0.00
Other Equity Adjustments -915.90M -132.78M -119.40M -202.43M
Total Capitalization 20.57B 22.28B 14.25B 10.55B
Total Equity 5.31B 5.12B 3.72B 4.01B
Total Liabilities & Stock Equity 26.35B 27.97B 17.95B 13.14B
Total Common Shares Outstanding 334.40M 333.04M 303.86M 306.37M
Preferred Shares 0.00 0.00 0.00 0.00
Treasury Shares 0.00 0.00 0.00 0.00
Basic Weighted Shares Outstanding 335.40M 321.00M 305.45M 304.66M
Diluted Weighted Shares Outstanding 341.50M 321.00M 305.45M 326.12M
Number of Employees 16800 17200 7000 6900
Number of Part-Time Employees 0 0 0 0
VRX News

VRX Valeant Pharmaceuticals International Inc

Chart of VRX

Analysts Ratings for VRX

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 6 6 6 6
Moderate Buy 2 2 2 2
Hold 2 2 2 2
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET VRX ANALYST REPORT

Brokerage Partners

VRX Chatter

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
Real Money Pro

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Trifecta Stocks

Trifecta Stocks analyzes over 4,000 equities weekly to find the elite 1% of stocks that pass rigorous quantitative, fundamental and technical tests.

Product Features:
  • Model portfolio
  • Trade alerts
  • Recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Growth Seeker

Bryan Ashenberg, using sophisticated stock screening and fundamental research, identifies potentially explosive small and mid-cap stocks.

Product Features:
  • Model portfolio
  • Small-cap and mid-cap focus
  • Intraday trade alerts
  • Weekly roundups
Options Profits

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
Top Rated Stocks Top Rated Funds Top Rated ETFs